Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $23.86 is 749.11% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 23.895||$ 23.94|
|Low:||$ 23.84||$ 2.81|
ETFs with ECYT as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.82%||Invesco DWA NASDAQ Momentum ETF (DWAQ)||-18.60 (-16.29%)|
|3.14%||Invesco DWA Healthcare Momentum ETF (PTH)||-14.46 (-15.41%)|
|2.03%||Invesco DWA SmallCap Momentum ETF (DWAS)||-9.11 (-16.09%)|
|0.44%||iShares Microcap ETF (IWC)||-18.16 (-16.86%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
We are a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. We use drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. Our agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen, or PSMA, in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. ... More ...
Nasdaq Official Price
Dec. 13, 2018
Dec. 13, 2018